BOEHRINGER INGLEHEIM PERSANTINE HEART VALVE STUDIES ARE "NEW" UNDER WAXMAN/HATCH DEFINITION AND JUSTIFY THREE YEARS OF EXCLUSIVITY, FDA SAYS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".